Literature DB >> 3683077

Correlation of adenosine receptor affinities and cardiovascular activity.

H W Hamilton1, M D Taylor, R P Steffen, S J Haleen, R F Bruns.   

Abstract

Binding affinities of 28 adenosine analogs at A1 adenosine receptors (rat whole brain membranes, [3H]N6-cyclohexyladenosine, CHA), and at A2 adenosine receptors (rat striatal membranes, [3H]NECA) were compared to their EC25 values for decreasing heart rate and increasing coronary flow in the isolated rat heart. Heart rate (an A1 response) correlated with A1 binding affinity (r2 = 0.71, p less than 0.0001) but not with A2 binding affinity (r2 = 0.007, n.s.); conversely, coronary flow (an A2 response) correlated with A2 binding affinity (r2 = 0.83, p less than 0.0001) but not with A1 binding affinity (r2 = 0.05, n.s.). These results confirm that the brain A1 and A2 receptors, studied by binding methods, bear close similarities to their respective counterparts in the heart, studied by means of functional responses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3683077     DOI: 10.1016/0024-3205(87)90542-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Cardiovascular selectivity of adenosine receptor agonists in anaesthetized dogs.

Authors:  R Z Gerencer; B A Finegan; A S Clanachan
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

2.  Influences of different adenosine receptor subtypes on catalepsy in mice.

Authors:  M R Zarrindast; M Modabber; M Sabetkasai
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Inhibition of platelet aggregation by adenosine receptor agonists.

Authors:  G Cristalli; S Vittori; R D Thompson; W L Padgett; D Shi; J W Daly; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

4.  Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo.

Authors:  R A Mathôt; E M Van der Wenden; W Soudijn; A P IJzerman; M Danhof
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

5.  Covalent binding of a selective agonist irreversibly activates guinea pig coronary artery A2 adenosine receptors.

Authors:  K Niiya; K A Jacobson; S K Silvia; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

6.  The cardiovascular effects of selective adenosine A1 and A2 receptor agonists in the pithed rat: no role for glibenclamide-sensitive potassium channels.

Authors:  J R Fozard; A M Carruthers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

7.  Adenosine-induced dilatation of the rabbit hepatic arterial bed is mediated by A2-purinoceptors.

Authors:  R T Mathie; B Alexander; V Ralevic; G Burnstock
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

8.  Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice.

Authors:  T G Heffner; J N Wiley; A E Williams; R F Bruns; L L Coughenour; D A Downs
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats.

Authors:  R A Mathôt; A Cleton; W Soudijn; A P IJzerman; M Danhof
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

10.  Pronounced cholinergic but only moderate purinergic effects in isolated atrial and ventricular heart muscle from cats.

Authors:  M Kemmer; H Jakob; H Nawrath
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.